Generate a tailored SOP for Dr. Kanmin Xue. Improve your application with a focused, well-structured draft.
Kanmin Xue is a Wellcome Trust clinician scientist fellow at the University of Oxford and an Honorary Consultant Vitreoretinal Surgeon at the Oxford Eye Hospital. His previous roles include being an Academic Clinical Lecturer at the National Institute Health Care Research (NIHR) from 2014 to 2018, where he focused on laboratory and clinical research in gene therapy for inherited retinal diseases and robotic eye surgery. He completed his ophthalmology training including a vitreoretinal fellowship at the Royal Victorian Eye and Ear Hospital in Melbourne, Australia, and conducted PhD research at the MRC Laboratory of Molecular Biology in Cambridge on DNA editing and antibody class switching. His research interests focus on understanding retinal degeneration, inflammation, and developing novel gene therapies for age-related macular degeneration and other retinal diseases. Kanmin leads the Retinal Disease Repair Group, utilizing approaches such as gene delivery, gene editing, and artificial intelligence in clinical trials and patient cohort studies. He is also actively involved in mentoring early career researchers within his team.
Oxford University Hospitals NHS Foundation Trust • Oxford
Honorary Consultant Vitreoretinal Surgeon involved in clinical research and treatment of retinal diseases.
National Institute of Health Care Research • Oxford
Conducted research on inherited retinal diseases and gene therapy.
Department of Politics and International Relations - Higher Level English requirement.